Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

mejotid 100
Connect with this vendor - Learn about this product

MEJOTID 100 - Azacitidine for Injection 100mg


Medicine composition: Azacitidine for Injection 100 mg/vial

Dosage Form: Vial

Packing: 1 Vial

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Anti Cancer Product

Similar to Vidaza/Azadine


Azacitidine(MEJOTID) is a pyrimidine nucleoside analog of cytidine. Azacitidine is believed to exert its antineoplastic effects by causing hypomethylation of DNA and direct cytotoxicity on abnormal Hematopoietic cells in the bone marrow. The concentration of Azacitidine required for maximum inhibition of DNA methylation in vitro does not cause major suppression of DNA synthesis. Hypomethylation may restore normal function to genes that are critical for differentiation and proliferation. The cytotoxic effects of Azacitidine cause the death of rapidly dividing cells, including cancer cells that are no longer responsive to the normal growth control mechanisms. non-proliferating cells are relatively insensitive to Azacitidine.